WO2000028922A1 - Stent having non-uniform structure - Google Patents

Stent having non-uniform structure Download PDF

Info

Publication number
WO2000028922A1
WO2000028922A1 PCT/US1999/026423 US9926423W WO0028922A1 WO 2000028922 A1 WO2000028922 A1 WO 2000028922A1 US 9926423 W US9926423 W US 9926423W WO 0028922 A1 WO0028922 A1 WO 0028922A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
length
along
differentiated
unit cells
Prior art date
Application number
PCT/US1999/026423
Other languages
French (fr)
Inventor
Rao K. T. Venkateswara
Original Assignee
Advanced Cardiovascular Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Cardiovascular Systems, Inc. filed Critical Advanced Cardiovascular Systems, Inc.
Priority to CA002312566A priority Critical patent/CA2312566A1/en
Priority to EP99972088A priority patent/EP1047357A1/en
Priority to AU14728/00A priority patent/AU1472800A/en
Priority to JP2000581972A priority patent/JP3626097B2/en
Publication of WO2000028922A1 publication Critical patent/WO2000028922A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/826Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0029Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter

Definitions

  • the present invention generally relates to intravascular stents and more particularly, pertains to specialized stent configurations for the treatment of vascular disease within non-uniform vessels such as, for example, a tapered artery, or at the ostium or bifurcation of an artery.
  • Stents or expandable grafts are implanted in a variety of body lumens in an effort to maintain their patency.
  • These devices typically are intraluminally implanted by use of a catheter which is inserted at an easily accessible location and then advanced to the deployment site.
  • the stent initially is maintained in a radially compressed or collapsed state to enable it to be maneuvered through the lumen. Once in position, the stent is deployed which, depending upon its construction, is achieved either automatically by, for example, removing a restraint, or actively by, for example, the inflation of a balloon about which the stent is carried on the catheter.
  • Intravascular stents currently in use typically are designed to expand or to be expanded within a diseased vessel to a given nominal diameter that is constant along the entire length of the stent.
  • the stent also typically is uniform along its entire length in terms of its radial strength, its longitudinal flexibility and its coverage, i.e., the actual area of stent material defining the surface of the deployed stent relative to the area of vessel covered thereby.
  • Most blood vessels are not of constant diameter, exhibiting either a natural taper or a narrowing, particularly near bifurcations. Blood vessels may be abruptly tapered over short lengths (less than 20mm), as in the carotid arteries, or gradually tapered over long lengths (greater than 20mm), as in the iliac arteries.
  • bifurcation sites in the human circulatory system include the vascular profile where the external and internal carotid arteries branch out from the common carotid artery.
  • the common carotid artery is 7-9 mm in diameter while the internal carotid artery is 4-6 mm in diameter.
  • a stent deployed therein must accommodate a 3-5 mm diameter change over a length of about 20-30 mm.
  • Another example involves the stenting of the renal arteries. In order to cover the entire ostial area, it is necessary for the stent to conform to the interior of the renal artery and to flare into the significantly larger aorta.
  • the lesions present at the ostium are typically hard and calcified requiring the stent to possess greater strength in that specific region. Similar requirements arise in the treatment of ostial disease at the bifurcation in native coronary arteries or bypass grafts and aorta-ostial disease in the peripheral (e.g., carotid, renal and iliac) arteries. Non-uniformities also may be present by virtue of a curved or tortuous configuration of the blood vessel at the diseased site.
  • a stent therefore is needed with which a non-uniform vessel may be uniformly supported to provide consistency in terms of coverage, radial strength, and longitudinal flexibility along its entire length.
  • a stent is needed that is capable of providing specific variations in terms of coverage, radial strength, and longitudinal flexibility at certain locations along its length, in order to accommodate varying needs along the length of a particular vessel.
  • a stent of the present invention may be constructed so as to provide uniform coverage, uniform radial strength and/or uniform longitudinal flexibility to a non- uniformly shaped deployment site such as a vessel that is tapered or bifurcated.
  • a non- uniformly shaped deployment site such as a vessel that is tapered or bifurcated.
  • such stent may be constructed to accommodate non-uniform requirements of a particular site, wherein specific variations in flexibility, radial strength or coverage are required at specific locations along such stent.
  • the desired functional differentiation is achieved with a stent that is structurally differentiated in a preselected manner. Dimensional or geometric differentiation, or both dimensional and geometric differentiation, are relied upon to impart the desired variations of functional characteristics to a particular stent.
  • Such structural differentiation may be gradual or abrupt and may include several different type of differentiations along the length of the stent.
  • a stent of the present invention constructed for deployment in a tapered vessel has a gradually increasing expansion ratio along is length. Such differentiation may be achieved with an assembly of axially aligned rings each with a serpentine structure, wherein each repeating pattern of serpentines defines a single unit cell. By selecting the size of the unit cells in successive rings to be increasingly wider, an increased amount of material becomes available for expansion. Upon expansion, such stent assumes the tapered shape of a truncated cone to match the shape of the tapered artery. Despite its tapered shape, the stent nonetheless provides uniform coverage of the walls of the tapered vessel as well as exhibits uniform radial strength and longitudinal flexibility along its entire length.
  • the stent may be alternatively constructed so as to expand into any of a variety of shapes or profiles to fit a particular application. Geometric or dimensional as well as both geometric and dimensional variations of the unit cell may be employed to achieve such functional variation.
  • a stent of the present invention may be non- uniformly constructed so as to attain a uniform diameter along its entire length while it exhibits preselected variations of coverage, radial strength, or longitudinal flexibility along its length.
  • This is achievable by, for example, varying the thickness of the serpentine elements while the width of each serpentine element is held constant, or by varying the number of unit cells in certain serpentine elements.
  • a similar result can be achieved by simultaneously varying the dimensions (i.e., strut width and/or thickness of the unit cell), or the geometry, or both the dimensions and the geometry of the individual unit cells.
  • FIGURE 1 is a greatly enlarged plan view of a longitudinally severed and flattened stent of the present invention, shown in the predeployed state.
  • FIG. 2 is a perspective view of the stent shown in FIG. 1, also in the predeployed state.
  • FIG. 3 is a greatly enlarged plan view of the longitudinally severed and flattened stent of FIG. 1, shown in the deployed state.
  • FIG. 4 is a perspective view of the stent shown in FIG. 3, also in the deployed state.
  • Stents of the present invention are specifically constructed for particular deployment sites and thereby overcome the shortcomings inherent in attempting to fit a uniform stent to a non-uniform site.
  • the non-uniformity of the site may include a taper, a bifurcation, an ostium, or any other variation in terms of dimensions or support requirements.
  • the stent is maneuvered into place in the conventional manner, such as by a catheter about which it is carried while in its collapsed state. Once in position, the stent is expanded such as by the inflation of one or more balloons, or in the case of self expanding stents, a confining sheath is removed to allow the stent to expand automatically.
  • the stent By providing a tapered stent for deployment within a tapered artery, uniform coverage, uniform radial strength and uniform stiffness nonetheless may be achieved along the entire length of the stent.
  • the versatility of the system of the present invention allows a non-uniform stent to be constructed that imparts enhanced coverage, strength or stiffness at preselected locations so as to, for example, provide the needed support requirements in a diseased ostium.
  • FIG. l illustrates stent 12 incorporating features of the present invention and more specifically, a stent for deployment in a tapered artery.
  • the stent typically is tubular in its overall shape, however, the drawing shows the stent in a longitudinally severed and flattened state in order to clearly display its structure.
  • the stent structure generally consists of a series of circumferentially extending serpentine elements (14, 16, ...30) that are interconnected by links 32 extending between adjacent se ⁇ entine elements.
  • Each of the se ⁇ entine elements may be characterized as being made up of a number of individual unit cells 34, wherein each such cell consists of link 32 attached to two adjacent U- or V-shaped ribs 36,38.
  • each se ⁇ entine element Adjacent se ⁇ entine elements are arranged such that the respective series of apexes are in phase, and in longitudinal alignment with one another. All links extend from the same side of the se ⁇ entine elements. In the embodiment illustrated, all links extend between the left edges of the individual se ⁇ entine element.
  • each se ⁇ entine element is differentiated relative to the adjacent se ⁇ entine elements in terms of the width of the se ⁇ entine pattern, i.e., the length of each rib element as well as of each link element.
  • each successive se ⁇ entine element is progressively wider than the previous element, consequently, the rib and link elements of the respective unit cells are longer.
  • the number of unit cells in each se ⁇ entine element remains unchanged, as does the thickness and width of all of the rib and spine elements.
  • FIG. 2 is a perspective view of stent 12 as it actually appears in use prior to deployment.
  • the overall tubular structure is of uniform diameter and each of the se ⁇ entine elements extend about the entire circumference of the device.
  • the individual se ⁇ entine elements are recognizable as rings while the individual links 32 extend only between adjacent rings.
  • the diameter of the stent is selected to be sufficiently small to allow passage through a patient's vasculature to the deployment site.
  • FIG. 3 illustrates the stent shown in FIGS. 1 and 2 in its deployed state. The device again is shown longitudinally severed and flattened in order to more clearly display its structure.
  • the expansion of the device results in a tapered shape wherein the wider se ⁇ entine elements shown towards the right side of the device expand to a greater extent than the narrower se ⁇ entine elements shown toward the left side of the device.
  • Such expansion results in a truncated cone shape when shown in perspective as in FIG. 4.
  • Each of U- or V-shaped ribs 36,38 assumes a wider, more open angle while the links 32 remain essentially stationary and aligned. The deformation and expansion of the ribs provides for the increase in the diameter of the device, yet the overall length of the stent remains essentially unchanged during deployment of the stent, since the links connect only adjacent rings to each other.
  • any shortening would not only reduce the total area supported by the device, but also could cause trauma to the surrounding tissue during deployment. Additionally, because more stent material is present in the larger diameter rings by virtue of the presence of the same number of longer ribs, the radial strength, coverage and stiffness of the stent remains fairly constant along its entire length.
  • the above-described variables can be selected such that the resulting stent is specifically tailored to a very specific anatomical requirement, be it the taper, bifurcation twist, or ostium of a vessel.
  • the same variables can be selected such that the resulting stent is specifically tailored to provide a desired radial strength, longitudinal flexibility, or coverage differentiation.
  • a stent of the present invention may be constructed using any number of well-known techniques.
  • a stainless steel tube is laser cut with the desired stent pattern as is known in the art.
  • Digital angiography and advanced computing algorithms are valuable tools that are readily useable to create a structurally differentiated stent that conforms to the natural profile of a vessel upon deployment.
  • Chemical etching or electro-polishing techniques which are well known, subsequently may be used to selectively vary the wall thickness of such stent.
  • Deployment maybe achieved by shaped balloons for balloon-expandable stents whereby a tapered balloon is used to expand a tapered stent within a tapered vessel.
  • multiple balloons of varying size may be used to achieve a similar effect, as may the tapered section of an over-sized balloon.
  • the stent may be constructed to be self-expanding by any of various techniques well known in the art. Deployment of a self-expanding stent can be achieved by subjecting the collapsed stent which is constructed of a shape memory alloy, to certain temperatures which cause it to expand. A stent constructed of elastic material may be forcefully collapsed and constrained within a sheath. Removal of the sheath allows the stent to automatically expand.
  • Balloon expandable stents may be manufactured from any number of ductile metals and alloys including, stainless steel, tantalum, and platinum-iridium alloys, either coated or uncoated.
  • Self-expanding stents are constructed of shape memory or superelastic materials or alloys such as NiTi alloys, including Nitinol, and Cu-Zn alloys.

Abstract

A stent (12) for use in a non-uniform deployment site such as in a tapered or bifurcated artery or in an ostial region. The stent (12) has a non-uniform structure selected to accommodate the non-uniformities inherent in the particular diseased area which it is intended to support. Non-uniformities can include differentiation in terms of its expansion ratio, radial strength, coverage and longitudinal flexibility.

Description

STENT HAVING NON-UNIFORM STRUCTURE
BACKGROUND OF THE INVENTION
The present invention generally relates to intravascular stents and more particularly, pertains to specialized stent configurations for the treatment of vascular disease within non-uniform vessels such as, for example, a tapered artery, or at the ostium or bifurcation of an artery. Stents or expandable grafts are implanted in a variety of body lumens in an effort to maintain their patency. These devices typically are intraluminally implanted by use of a catheter which is inserted at an easily accessible location and then advanced to the deployment site. The stent initially is maintained in a radially compressed or collapsed state to enable it to be maneuvered through the lumen. Once in position, the stent is deployed which, depending upon its construction, is achieved either automatically by, for example, removing a restraint, or actively by, for example, the inflation of a balloon about which the stent is carried on the catheter.
Intravascular stents currently in use typically are designed to expand or to be expanded within a diseased vessel to a given nominal diameter that is constant along the entire length of the stent. The stent also typically is uniform along its entire length in terms of its radial strength, its longitudinal flexibility and its coverage, i.e., the actual area of stent material defining the surface of the deployed stent relative to the area of vessel covered thereby. Most blood vessels, however, are not of constant diameter, exhibiting either a natural taper or a narrowing, particularly near bifurcations. Blood vessels may be abruptly tapered over short lengths (less than 20mm), as in the carotid arteries, or gradually tapered over long lengths (greater than 20mm), as in the iliac arteries. Examples of bifurcation sites in the human circulatory system include the vascular profile where the external and internal carotid arteries branch out from the common carotid artery. The common carotid artery is 7-9 mm in diameter while the internal carotid artery is 4-6 mm in diameter. In the event disease is present at such junction, a stent deployed therein must accommodate a 3-5 mm diameter change over a length of about 20-30 mm. Another example involves the stenting of the renal arteries. In order to cover the entire ostial area, it is necessary for the stent to conform to the interior of the renal artery and to flare into the significantly larger aorta. Moreover, the lesions present at the ostium are typically hard and calcified requiring the stent to possess greater strength in that specific region. Similar requirements arise in the treatment of ostial disease at the bifurcation in native coronary arteries or bypass grafts and aorta-ostial disease in the peripheral (e.g., carotid, renal and iliac) arteries. Non-uniformities also may be present by virtue of a curved or tortuous configuration of the blood vessel at the diseased site.
By fitting conventionally configured stents, i.e., stents of uniform shape and diameter, to such sites, a number of problems arise. In the event such stent is fitted to a tapered section of artery, either the artery is forced into an unnatural shape, or the stent must somehow become distorted during its deployment. By forcing the artery into an unnatural shape, certain sections of the tissue are caused to be overextended or other sections to be undersupported. Steps taken in an effort to non-uniformly expand a uniformly constructed stent have the effect of imparting undesired non-uniform characteristics to the device such as non-uniform radial strength, flexibility, and coverage. Another potential side effect associated with the use of a stent of uniform construction is that its deployment in a tortuous segment of vasculature would cause an undesirable straightening of such segment.
A stent therefore is needed with which a non-uniform vessel may be uniformly supported to provide consistency in terms of coverage, radial strength, and longitudinal flexibility along its entire length. Alternatively, a stent is needed that is capable of providing specific variations in terms of coverage, radial strength, and longitudinal flexibility at certain locations along its length, in order to accommodate varying needs along the length of a particular vessel.
SUMMARY OF THE INVENTION
A stent of the present invention may be constructed so as to provide uniform coverage, uniform radial strength and/or uniform longitudinal flexibility to a non- uniformly shaped deployment site such as a vessel that is tapered or bifurcated. Alternatively, such stent may be constructed to accommodate non-uniform requirements of a particular site, wherein specific variations in flexibility, radial strength or coverage are required at specific locations along such stent. The desired functional differentiation is achieved with a stent that is structurally differentiated in a preselected manner. Dimensional or geometric differentiation, or both dimensional and geometric differentiation, are relied upon to impart the desired variations of functional characteristics to a particular stent. Such structural differentiation may be gradual or abrupt and may include several different type of differentiations along the length of the stent.
A stent of the present invention constructed for deployment in a tapered vessel has a gradually increasing expansion ratio along is length. Such differentiation may be achieved with an assembly of axially aligned rings each with a serpentine structure, wherein each repeating pattern of serpentines defines a single unit cell. By selecting the size of the unit cells in successive rings to be increasingly wider, an increased amount of material becomes available for expansion. Upon expansion, such stent assumes the tapered shape of a truncated cone to match the shape of the tapered artery. Despite its tapered shape, the stent nonetheless provides uniform coverage of the walls of the tapered vessel as well as exhibits uniform radial strength and longitudinal flexibility along its entire length. The stent may be alternatively constructed so as to expand into any of a variety of shapes or profiles to fit a particular application. Geometric or dimensional as well as both geometric and dimensional variations of the unit cell may be employed to achieve such functional variation.
As a further alternative, a stent of the present invention may be non- uniformly constructed so as to attain a uniform diameter along its entire length while it exhibits preselected variations of coverage, radial strength, or longitudinal flexibility along its length. This is achievable by, for example, varying the thickness of the serpentine elements while the width of each serpentine element is held constant, or by varying the number of unit cells in certain serpentine elements. A similar result can be achieved by simultaneously varying the dimensions (i.e., strut width and/or thickness of the unit cell), or the geometry, or both the dimensions and the geometry of the individual unit cells.
These and other features and advantages of the present invention will become apparent from the following detailed description of a preferred embodiment which, when taken in conjunction with the accompanying drawings, illustrates by way of example the principles of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a greatly enlarged plan view of a longitudinally severed and flattened stent of the present invention, shown in the predeployed state.
FIG. 2 is a perspective view of the stent shown in FIG. 1, also in the predeployed state.
FIG. 3 is a greatly enlarged plan view of the longitudinally severed and flattened stent of FIG. 1, shown in the deployed state. FIG. 4 is a perspective view of the stent shown in FIG. 3, also in the deployed state.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Stents of the present invention are specifically constructed for particular deployment sites and thereby overcome the shortcomings inherent in attempting to fit a uniform stent to a non-uniform site. The non-uniformity of the site may include a taper, a bifurcation, an ostium, or any other variation in terms of dimensions or support requirements. The stent is maneuvered into place in the conventional manner, such as by a catheter about which it is carried while in its collapsed state. Once in position, the stent is expanded such as by the inflation of one or more balloons, or in the case of self expanding stents, a confining sheath is removed to allow the stent to expand automatically. Subsequent withdrawal of the catheter and associated deployment devices leaves the stent in place to maintain the patency of the vessel. By providing a tapered stent for deployment within a tapered artery, uniform coverage, uniform radial strength and uniform stiffness nonetheless may be achieved along the entire length of the stent. Alternatively, the versatility of the system of the present invention allows a non-uniform stent to be constructed that imparts enhanced coverage, strength or stiffness at preselected locations so as to, for example, provide the needed support requirements in a diseased ostium.
FIG. l illustrates stent 12 incorporating features of the present invention and more specifically, a stent for deployment in a tapered artery. The stent typically is tubular in its overall shape, however, the drawing shows the stent in a longitudinally severed and flattened state in order to clearly display its structure. The stent structure generally consists of a series of circumferentially extending serpentine elements (14, 16, ...30) that are interconnected by links 32 extending between adjacent seφentine elements. Each of the seφentine elements may be characterized as being made up of a number of individual unit cells 34, wherein each such cell consists of link 32 attached to two adjacent U- or V-shaped ribs 36,38. In the embodiment illustrated, a total of four unit cells define each seφentine element. Adjacent seφentine elements are arranged such that the respective series of apexes are in phase, and in longitudinal alignment with one another. All links extend from the same side of the seφentine elements. In the embodiment illustrated, all links extend between the left edges of the individual seφentine element. In the embodiment illustrated in FIG. 1 , each seφentine element is differentiated relative to the adjacent seφentine elements in terms of the width of the seφentine pattern, i.e., the length of each rib element as well as of each link element. In the particular embodiment shown, each successive seφentine element is progressively wider than the previous element, consequently, the rib and link elements of the respective unit cells are longer. The number of unit cells in each seφentine element, however, remains unchanged, as does the thickness and width of all of the rib and spine elements.
FIG. 2 is a perspective view of stent 12 as it actually appears in use prior to deployment. The overall tubular structure is of uniform diameter and each of the seφentine elements extend about the entire circumference of the device. The individual seφentine elements are recognizable as rings while the individual links 32 extend only between adjacent rings. The diameter of the stent is selected to be sufficiently small to allow passage through a patient's vasculature to the deployment site. FIG. 3 illustrates the stent shown in FIGS. 1 and 2 in its deployed state. The device again is shown longitudinally severed and flattened in order to more clearly display its structure. As is clearly visible, the expansion of the device results in a tapered shape wherein the wider seφentine elements shown towards the right side of the device expand to a greater extent than the narrower seφentine elements shown toward the left side of the device. Such expansion results in a truncated cone shape when shown in perspective as in FIG. 4. Each of U- or V-shaped ribs 36,38 assumes a wider, more open angle while the links 32 remain essentially stationary and aligned. The deformation and expansion of the ribs provides for the increase in the diameter of the device, yet the overall length of the stent remains essentially unchanged during deployment of the stent, since the links connect only adjacent rings to each other. This is a highly desirable characteristic of a stent, as any shortening would not only reduce the total area supported by the device, but also could cause trauma to the surrounding tissue during deployment. Additionally, because more stent material is present in the larger diameter rings by virtue of the presence of the same number of longer ribs, the radial strength, coverage and stiffness of the stent remains fairly constant along its entire length.
While the figures illustrate the structure of a single embodiment of the present invention and the distortion it undergoes during deployment, it should be understood that vast numbers of variations are possible to enable a stent to be tailored to the specific requirements of a particular application. By varying or differentiating the geometry of the stent's structure or of the individual unit cells, a commensurate variation or differentiation in function is achieved. Functional differentiation also is achievable by varying the thickness or width of the individual ribs. Desired functional differences also are achievable by varying the number of unit cells either gradually along the length of the stent or in isolated locations thereon. Both the number of unit cells, the geometry of such cells, and the dimensions of such cells may be varied in any combination to achieve a particular functional effect.
The above-described variables can be selected such that the resulting stent is specifically tailored to a very specific anatomical requirement, be it the taper, bifurcation twist, or ostium of a vessel. In addition to fitting the dimensional requirements of a particular non-uniformity in the anatomy, the same variables can be selected such that the resulting stent is specifically tailored to provide a desired radial strength, longitudinal flexibility, or coverage differentiation.
A stent of the present invention may be constructed using any number of well-known techniques. Preferably, a stainless steel tube is laser cut with the desired stent pattern as is known in the art. Digital angiography and advanced computing algorithms are valuable tools that are readily useable to create a structurally differentiated stent that conforms to the natural profile of a vessel upon deployment. Chemical etching or electro-polishing techniques, which are well known, subsequently may be used to selectively vary the wall thickness of such stent.
Deployment maybe achieved by shaped balloons for balloon-expandable stents whereby a tapered balloon is used to expand a tapered stent within a tapered vessel. Alternatively, multiple balloons of varying size may be used to achieve a similar effect, as may the tapered section of an over-sized balloon. As a further alternative, the stent may be constructed to be self-expanding by any of various techniques well known in the art. Deployment of a self-expanding stent can be achieved by subjecting the collapsed stent which is constructed of a shape memory alloy, to certain temperatures which cause it to expand. A stent constructed of elastic material may be forcefully collapsed and constrained within a sheath. Removal of the sheath allows the stent to automatically expand.
Balloon expandable stents may be manufactured from any number of ductile metals and alloys including, stainless steel, tantalum, and platinum-iridium alloys, either coated or uncoated. Self-expanding stents are constructed of shape memory or superelastic materials or alloys such as NiTi alloys, including Nitinol, and Cu-Zn alloys.
While a particular form of the invention has been illustrated and described, it also will be apparent to those skilled in the art that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited except by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A stent for supporting a vascular region having non-uniform support requirements, comprising: a structure, differentiated so as to provide support in a non-uniform manner to accommodate said non-uniform support requirements.
2. The stent of claim 1 , wherein said structure is differentiated so as to expand to different diameters along its length while exhibiting substantially constant radial strength along its length.
3. The stent of claim 1 , wherein said structure is differentiated to provide a constant amount of coverage along its length.
4. The stent of claim 3, wherein said structure is differentiated so as to expand to a truncated cone shape in order to accommodate a similarly tapered artery.
5. The stent of claim 1 , wherein said structure is differentiated so as to expand to a constant diameter along its length while exhibiting a preselected variation in radial strength along its length.
6. The stent of claim 1 , wherein said structure is differentiated so as to expand to a constant diameter along its length while providing a preselected variation in coverage along its length.
7. The stent of claim 1 , wherein said structure is comprised of an assembly of unit cells and wherein the dimensions of said individual unit cells and the number of said unit cells vary along the length of said stent.
8. The stent of claim 1 , wherein said structure is comprised of an assembly of unit cells and wherein the geometry of individual cells vary along the length of said stent.
9. The stent of claim 8, wherein said unit cells additionally vary with respect to their dimensions.
10. The stent of claim 1, wherein said structure is formed by laser cutting voids into a tube.
11. The stent of claim 1, wherein said structure is formed of wire.
12. A stent for supporting a vascular region having a tapered shape, comprising: a structure, differentiated so as to expand to said tapered shape while providing constant support along it length.
13. The stent of claim 12 comprising, an assembly of expandable rings and wherein the width of each successive ring is increased.
14. The stent of claim 13, wherein each ring comprises a seφentine structure.
15. The stent of claim 14, wherein each of said seφentine structures comprises a plurality of repeating unit cells, each unit cell consisting of a longitudinally oriented link from which two deformable generally U- or V-shaped ribs extend.
16. The stent of claim 15, wherein the lengths of said link and said ribs for each unit cell are selected to impart a preselected diameter to said stent upon expansion.
17. The stent of claim 12, wherein said structure is formed by laser cutting voids into a tube.
8. The stent of claim 12, wherein said structure is formed of wire.
PCT/US1999/026423 1998-11-12 1999-11-09 Stent having non-uniform structure WO2000028922A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002312566A CA2312566A1 (en) 1998-11-12 1999-11-09 Stent having non-uniform structure
EP99972088A EP1047357A1 (en) 1998-11-12 1999-11-09 Stent having non-uniform structure
AU14728/00A AU1472800A (en) 1998-11-12 1999-11-09 Stent having non-uniform structure
JP2000581972A JP3626097B2 (en) 1998-11-12 1999-11-09 Improved stent configuration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19104398A 1998-11-12 1998-11-12
US09/191,043 1998-11-12

Publications (1)

Publication Number Publication Date
WO2000028922A1 true WO2000028922A1 (en) 2000-05-25

Family

ID=22703901

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/026423 WO2000028922A1 (en) 1998-11-12 1999-11-09 Stent having non-uniform structure

Country Status (6)

Country Link
EP (1) EP1047357A1 (en)
JP (1) JP3626097B2 (en)
CN (1) CN1287478A (en)
AU (1) AU1472800A (en)
CA (1) CA2312566A1 (en)
WO (1) WO2000028922A1 (en)

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001006954A1 (en) * 1999-07-22 2001-02-01 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
WO2002013727A1 (en) * 2000-08-16 2002-02-21 Edwards Lifesciences Corporation Stent for implantation into the carotid artery formed by process using intraluminal mapping
WO2003015666A2 (en) * 2001-08-15 2003-02-27 Edwards Lifesciences Corporation Virtual stent making process derived from endoluminal mapping
JP2004517697A (en) * 2000-09-22 2004-06-17 ボストン サイエンティフィック リミテッド Flexible and expandable stent
US6981986B1 (en) * 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
WO2006034062A1 (en) * 2004-09-17 2006-03-30 Gi Dynamics, Inc. Gastrointestinal anchor
WO2006113024A1 (en) * 2005-04-13 2006-10-26 Advanced Cardiovascular Systems, Inc. Intravascular stent
EP1734897A1 (en) * 2004-03-31 2006-12-27 Merlin MD PTE Ltd A method for treating aneurysms
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
WO2007094020A1 (en) * 2006-02-17 2007-08-23 Invatec S.R.L. Endoluminal prosthesis
EP1560542A4 (en) * 2002-11-11 2009-01-07 Devax Inc Endoprosthesis deployment system for treating vascular bifurcations
US7682330B2 (en) 2003-12-09 2010-03-23 Gi Dynamics, Inc. Intestinal sleeve
WO2010053563A1 (en) 2008-11-06 2010-05-14 William Cook Europe Aps Stent member
US20100198333A1 (en) * 2009-01-31 2010-08-05 Macatangay Edwin E Preform for and an endoluminal prosthesis
US7935073B2 (en) 2002-12-02 2011-05-03 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US8021414B2 (en) * 1996-04-26 2011-09-20 Boston Scientific Scimed, Inc. Intravascular stent
US20110230957A1 (en) * 2009-11-04 2011-09-22 Bonsignore Craig L Alternating circumferential bridge stent design and methods for use thereof
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
ES2374382A1 (en) * 2011-10-27 2012-02-16 Javier Gallastegui Goiburu Stent
US8137301B2 (en) 2002-12-02 2012-03-20 Gi Dynamics, Inc. Bariatric sleeve
US8211163B2 (en) * 2006-09-13 2012-07-03 Boston Scientific Scimed, Inc. Hybrid symmetrical stent designs
US8221489B2 (en) 2009-08-20 2012-07-17 Stentys Device and method for treating a body lumen
ITBS20120154A1 (en) * 2012-10-30 2014-05-01 Pierfrancesco Veroux VENOUS ENDOLUMINAL DEVICE FOR THE TREATMENT OF VENETIAN DEFECTS
WO2014068412A1 (en) * 2012-10-30 2014-05-08 Veroux Pierfrancesco Improved venous endoluminal device for the treatment of defects of the veins
US8801647B2 (en) 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US8920430B2 (en) 2004-03-31 2014-12-30 Merlin Md Pte. Ltd. Medical device
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
DE102013111593A1 (en) * 2013-10-21 2015-04-23 Jotec Gmbh Vascular implant with areas of different radial force
WO2015062532A1 (en) * 2013-10-31 2015-05-07 微创心脉医疗科技(上海)有限公司 Coated stent graft
US9149377B2 (en) 2008-10-10 2015-10-06 Veryan Medical Ltd. Stent suitable for deployment in a blood vessel
US9216082B2 (en) 2005-12-22 2015-12-22 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9233014B2 (en) 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
EP2349129B1 (en) * 2008-10-10 2016-05-04 Veryan Medical Limited A stent suitable for deployment in a blood vessel
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US9492297B2 (en) 2006-09-12 2016-11-15 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US9492293B2 (en) 2001-03-13 2016-11-15 Medinol Ltd. Method and apparatus for stenting
US9839513B2 (en) 2007-10-25 2017-12-12 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US9901474B2 (en) 2002-12-02 2018-02-27 Gi Dynamics, Inc. Anti-obesity devices
US9925031B2 (en) 2009-12-28 2018-03-27 Cook Medical Technologies Llc Endoluminal device with kink-resistant regions
WO2018112203A1 (en) * 2016-12-14 2018-06-21 eLum Technologies, Inc. Electrospun stents, flow diverters, and occlusion devices and methods of making the same
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10258464B2 (en) 2012-03-22 2019-04-16 Symetis Sa Transcatheter stent-valves
US10271974B2 (en) 2011-06-24 2019-04-30 Cook Medical Technologies Llc Helical stent
US10376359B2 (en) 2009-11-02 2019-08-13 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US10716662B2 (en) 2007-08-21 2020-07-21 Boston Scientific Limited Stent-valves for valve replacement and associated methods and systems for surgery
CN112118812A (en) * 2018-03-29 2020-12-22 萨哈詹德医疗技术私人有限公司 Support frame
EP1906883B1 (en) 2005-05-24 2021-01-27 Corevalve, Inc. A non-cylindrical prosthetic valve system for transluminal delivery
US10987208B2 (en) 2012-04-06 2021-04-27 Merlin Md Pte Ltd. Devices and methods for treating an aneurysm
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715340B2 (en) 2004-03-31 2014-05-06 Merlin Md Pte Ltd. Endovascular device with membrane
US9820746B2 (en) * 2008-07-28 2017-11-21 Incube Laboratories LLC System and method for scaffolding anastomoses
CN106880430B (en) * 2017-03-07 2019-05-24 北京迈迪顶峰医疗科技有限公司 A kind of lung arterial support

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045627A1 (en) * 1980-07-31 1982-02-10 RAYCHEM CORPORATION (a California corporation) Enhanced recovery memory metal device
US5617878A (en) * 1996-05-31 1997-04-08 Taheri; Syde A. Stent and method for treatment of aortic occlusive disease
WO1997025937A1 (en) * 1996-01-18 1997-07-24 Jang G David Programmable variably flexible modular stents
WO1998020927A1 (en) * 1996-11-12 1998-05-22 Valerian Voinov The optimum expandable stent mechanical model and its application
WO1998032412A2 (en) * 1997-01-24 1998-07-30 Scimed Life Systems Inc Bistable spring construction for a stent and other medical apparatus
WO1999017680A1 (en) * 1997-10-03 1999-04-15 Localmed, Inc. Radially expansible vessel scaffold having beams and expansion joints
WO1999039661A2 (en) * 1998-02-05 1999-08-12 Medtronic, Inc. Radially-expandable stent and delivery system
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045627A1 (en) * 1980-07-31 1982-02-10 RAYCHEM CORPORATION (a California corporation) Enhanced recovery memory metal device
WO1997025937A1 (en) * 1996-01-18 1997-07-24 Jang G David Programmable variably flexible modular stents
US5617878A (en) * 1996-05-31 1997-04-08 Taheri; Syde A. Stent and method for treatment of aortic occlusive disease
WO1998020927A1 (en) * 1996-11-12 1998-05-22 Valerian Voinov The optimum expandable stent mechanical model and its application
WO1998032412A2 (en) * 1997-01-24 1998-07-30 Scimed Life Systems Inc Bistable spring construction for a stent and other medical apparatus
WO1999017680A1 (en) * 1997-10-03 1999-04-15 Localmed, Inc. Radially expansible vessel scaffold having beams and expansion joints
WO1999039661A2 (en) * 1998-02-05 1999-08-12 Medtronic, Inc. Radially-expandable stent and delivery system
US5938697A (en) * 1998-03-04 1999-08-17 Scimed Life Systems, Inc. Stent having variable properties

Cited By (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6981986B1 (en) * 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US9078778B2 (en) 1996-04-26 2015-07-14 Boston Scientific Scimed, Inc. Intravascular stent
US8021414B2 (en) * 1996-04-26 2011-09-20 Boston Scientific Scimed, Inc. Intravascular stent
WO2001006954A1 (en) * 1999-07-22 2001-02-01 Advanced Cardiovascular Systems, Inc. Tapered self-expanding stent
US7226475B2 (en) 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
WO2002013727A1 (en) * 2000-08-16 2002-02-21 Edwards Lifesciences Corporation Stent for implantation into the carotid artery formed by process using intraluminal mapping
JP2004517697A (en) * 2000-09-22 2004-06-17 ボストン サイエンティフィック リミテッド Flexible and expandable stent
EP1318765B2 (en) 2000-09-22 2011-11-23 Boston Scientific Limited Flexible and expandable stent
US9492293B2 (en) 2001-03-13 2016-11-15 Medinol Ltd. Method and apparatus for stenting
WO2003015666A2 (en) * 2001-08-15 2003-02-27 Edwards Lifesciences Corporation Virtual stent making process derived from endoluminal mapping
WO2003015666A3 (en) * 2001-08-15 2004-03-18 Edwards Lifesciences Corp Virtual stent making process derived from endoluminal mapping
EP1560542A4 (en) * 2002-11-11 2009-01-07 Devax Inc Endoprosthesis deployment system for treating vascular bifurcations
US8162871B2 (en) 2002-12-02 2012-04-24 Gi Dynamics, Inc. Bariatric sleeve
US9155609B2 (en) 2002-12-02 2015-10-13 Gi Dynamics, Inc. Bariatric sleeve
US9750596B2 (en) 2002-12-02 2017-09-05 Gi Dynamics, Inc. Bariatric sleeve
US8870806B2 (en) 2002-12-02 2014-10-28 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US8137301B2 (en) 2002-12-02 2012-03-20 Gi Dynamics, Inc. Bariatric sleeve
US9901474B2 (en) 2002-12-02 2018-02-27 Gi Dynamics, Inc. Anti-obesity devices
US7935073B2 (en) 2002-12-02 2011-05-03 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US9278020B2 (en) 2002-12-02 2016-03-08 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US9237944B2 (en) 2003-12-09 2016-01-19 Gi Dynamics, Inc. Intestinal sleeve
US7981163B2 (en) 2003-12-09 2011-07-19 Gi Dynamics, Inc. Intestinal sleeve
US9084669B2 (en) 2003-12-09 2015-07-21 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US7815589B2 (en) 2003-12-09 2010-10-19 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US9095416B2 (en) 2003-12-09 2015-08-04 Gi Dynamics, Inc. Removal and repositioning devices
US7682330B2 (en) 2003-12-09 2010-03-23 Gi Dynamics, Inc. Intestinal sleeve
US9744061B2 (en) 2003-12-09 2017-08-29 Gi Dynamics, Inc. Intestinal sleeve
US8834405B2 (en) 2003-12-09 2014-09-16 Gi Dynamics, Inc. Intestinal sleeve
US8303669B2 (en) 2003-12-09 2012-11-06 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US8771219B2 (en) 2003-12-09 2014-07-08 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US9585783B2 (en) 2003-12-09 2017-03-07 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US8628583B2 (en) 2003-12-09 2014-01-14 Gi Dynamics, Inc. Methods and apparatus for anchoring within the gastrointestinal tract
US10390934B2 (en) 2004-03-31 2019-08-27 Merlin Md Pte. Ltd. Medical device
EP1734897A1 (en) * 2004-03-31 2006-12-27 Merlin MD PTE Ltd A method for treating aneurysms
US9844433B2 (en) 2004-03-31 2017-12-19 Merlin Md Pte. Ltd. Medical device
US9433518B2 (en) 2004-03-31 2016-09-06 Merlin Md Pte. Ltd. Medical device
US11033378B2 (en) 2004-03-31 2021-06-15 Merlin Md Pte Ltd. Medical device
US9585668B2 (en) 2004-03-31 2017-03-07 Merlin Md Pte Ltd Medical device
US8920430B2 (en) 2004-03-31 2014-12-30 Merlin Md Pte. Ltd. Medical device
EP1734897A4 (en) * 2004-03-31 2010-12-22 Merlin Md Pte Ltd A method for treating aneurysms
EP3195829A1 (en) * 2004-09-17 2017-07-26 GI Dynamics, Inc. Gastrointestinal achor
WO2006034062A1 (en) * 2004-09-17 2006-03-30 Gi Dynamics, Inc. Gastrointestinal anchor
US7815591B2 (en) 2004-09-17 2010-10-19 Gi Dynamics, Inc. Atraumatic gastrointestinal anchor
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
WO2006113024A1 (en) * 2005-04-13 2006-10-26 Advanced Cardiovascular Systems, Inc. Intravascular stent
US8628565B2 (en) 2005-04-13 2014-01-14 Abbott Cardiovascular Systems Inc. Intravascular stent
EP1906883B1 (en) 2005-05-24 2021-01-27 Corevalve, Inc. A non-cylindrical prosthetic valve system for transluminal delivery
US8425451B2 (en) 2005-06-08 2013-04-23 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
US9216082B2 (en) 2005-12-22 2015-12-22 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9839515B2 (en) 2005-12-22 2017-12-12 Symetis, SA Stent-valves for valve replacement and associated methods and systems for surgery
US10314701B2 (en) 2005-12-22 2019-06-11 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10299922B2 (en) 2005-12-22 2019-05-28 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US10265167B2 (en) 2005-12-22 2019-04-23 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US8778010B2 (en) 2006-02-17 2014-07-15 Medtronic, Inc. Endoluminal prosthesis
WO2007094020A1 (en) * 2006-02-17 2007-08-23 Invatec S.R.L. Endoluminal prosthesis
AU2006338440B2 (en) * 2006-02-17 2012-10-25 Invatec S.R.L. Endoluminal prosthesis
EP2387973B1 (en) 2006-09-07 2020-11-25 Symetis SA Stent-valve delivery system
US9492297B2 (en) 2006-09-12 2016-11-15 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US8211163B2 (en) * 2006-09-13 2012-07-03 Boston Scientific Scimed, Inc. Hybrid symmetrical stent designs
US8801647B2 (en) 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US10716662B2 (en) 2007-08-21 2020-07-21 Boston Scientific Limited Stent-valves for valve replacement and associated methods and systems for surgery
US10219897B2 (en) 2007-10-25 2019-03-05 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US11452598B2 (en) 2007-10-25 2022-09-27 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US10709557B2 (en) 2007-10-25 2020-07-14 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US9839513B2 (en) 2007-10-25 2017-12-12 Symetis Sa Stents, valved-stents and methods and systems for delivery thereof
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US9149377B2 (en) 2008-10-10 2015-10-06 Veryan Medical Ltd. Stent suitable for deployment in a blood vessel
EP2349129B1 (en) * 2008-10-10 2016-05-04 Veryan Medical Limited A stent suitable for deployment in a blood vessel
US9314353B2 (en) 2008-10-10 2016-04-19 Veryan Medical Limited Stent suitable for deployment in a blood vessel
JP2012507387A (en) * 2008-11-06 2012-03-29 ウィリアム クック ユーロープ アーペーエス Stent member
WO2010053563A1 (en) 2008-11-06 2010-05-14 William Cook Europe Aps Stent member
US8092516B2 (en) 2008-11-06 2012-01-10 Cook Medical Technologies Llc Stent member
US20100198333A1 (en) * 2009-01-31 2010-08-05 Macatangay Edwin E Preform for and an endoluminal prosthesis
US8926687B2 (en) 2009-01-31 2015-01-06 Cook Medical Technologies Llc Preform for and an endoluminal prosthesis
US8641753B2 (en) * 2009-01-31 2014-02-04 Cook Medical Technologies Llc Preform for and an endoluminal prosthesis
US8221489B2 (en) 2009-08-20 2012-07-17 Stentys Device and method for treating a body lumen
US10376359B2 (en) 2009-11-02 2019-08-13 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10744012B2 (en) 2009-11-04 2020-08-18 Boston Scientific Scimed, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US20110230957A1 (en) * 2009-11-04 2011-09-22 Bonsignore Craig L Alternating circumferential bridge stent design and methods for use thereof
US9925031B2 (en) 2009-12-28 2018-03-27 Cook Medical Technologies Llc Endoluminal device with kink-resistant regions
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US9233014B2 (en) 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
US10271974B2 (en) 2011-06-24 2019-04-30 Cook Medical Technologies Llc Helical stent
ES2374382A1 (en) * 2011-10-27 2012-02-16 Javier Gallastegui Goiburu Stent
US10898321B2 (en) 2012-03-22 2021-01-26 Symetis Sa Transcatheter stent-valves
US10258464B2 (en) 2012-03-22 2019-04-16 Symetis Sa Transcatheter stent-valves
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US10987208B2 (en) 2012-04-06 2021-04-27 Merlin Md Pte Ltd. Devices and methods for treating an aneurysm
WO2014068412A1 (en) * 2012-10-30 2014-05-08 Veroux Pierfrancesco Improved venous endoluminal device for the treatment of defects of the veins
US10952839B2 (en) 2012-10-30 2021-03-23 Pierfrancesco VEROUX Venous endoluminal devices for the treatment of defects of veins
ITBS20120154A1 (en) * 2012-10-30 2014-05-01 Pierfrancesco Veroux VENOUS ENDOLUMINAL DEVICE FOR THE TREATMENT OF VENETIAN DEFECTS
AU2013340418B2 (en) * 2012-10-30 2018-05-17 Pierfrancesco VEROUX Improved venous endoluminal device for the treatment of defects of the veins
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
DE102013111593A1 (en) * 2013-10-21 2015-04-23 Jotec Gmbh Vascular implant with areas of different radial force
WO2015062532A1 (en) * 2013-10-31 2015-05-07 微创心脉医疗科技(上海)有限公司 Coated stent graft
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
WO2018112203A1 (en) * 2016-12-14 2018-06-21 eLum Technologies, Inc. Electrospun stents, flow diverters, and occlusion devices and methods of making the same
CN112118812A (en) * 2018-03-29 2020-12-22 萨哈詹德医疗技术私人有限公司 Support frame

Also Published As

Publication number Publication date
EP1047357A1 (en) 2000-11-02
AU1472800A (en) 2000-06-05
JP2002529193A (en) 2002-09-10
CN1287478A (en) 2001-03-14
JP3626097B2 (en) 2005-03-02
CA2312566A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
EP1047357A1 (en) Stent having non-uniform structure
US6159238A (en) Stent having variable properties and method of its use
US6027526A (en) Stent having varied amounts of structural strength along its length
AU743158B2 (en) A profiled stent and method of manufacture
EP0876805B2 (en) Intravascular stent and stent delivery system for ostial vessel obstructions
US8721705B2 (en) Non-foreshortening intraluminal prosthesis
US6569193B1 (en) Tapered self-expanding stent
US5911732A (en) Articulated expandable intraluminal stent
WO2002053204A2 (en) Stent design with increased vessel coverage
WO2001015632A1 (en) Stent design with end rings having enhanced strength and radiopacity
US20060287708A1 (en) Small vessel expandable stent and method for production of same
EP2088963B1 (en) Bifurcation stent design with over expansion capability
MXPA00003782A (en) Stent having non-uniform structure

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99802014.1

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2000 14728

Country of ref document: AU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/003782

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 504115

Country of ref document: NZ

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2312566

Country of ref document: CA

Ref document number: 2312566

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1999972088

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2000 581972

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 14728/00

Country of ref document: AU

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1999972088

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999972088

Country of ref document: EP